About SeraCare
SeraCare is a company based in Milford (United States) founded in 1984 by Nelson Teng was acquired by LGC in November 2018. SeraCare has completed 2 acquisitions, including American Plasma Energy and KPL. SeraCare offers products and services including NGS Solutions, Controls & Reference Materials, and Custom Services. SeraCare operates in a competitive market with competitors including Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
- Headquarter Milford, United States
- Founders Nelson Teng
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
LGC
& 3 more
-
Employee Count
Not available
-
Investments & Acquisitions
American Plasma Energy
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SeraCare
SeraCare offers a comprehensive portfolio of products and services, including NGS Solutions, Controls & Reference Materials, and Custom Services.
Tools for next-generation sequencing in clinical diagnostics
Materials for validating and monitoring assay performance
Tailored solutions for NGS and serology controls
People of SeraCare
Unlock access to complete
Funding Insights of SeraCare
Investors in SeraCare
SeraCare has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include LGC, MidCap Financial and Five Points Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
U.S. lower middle market investments are managed by the firm.
|
Locked | Locked | Locked | |
|
Private debt funds are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Private equity investments are focused on the healthcare sector.
|
Locked | Locked | Locked |
Investor details for SeraCare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SeraCare
SeraCare has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include American Plasma Energy and KPL.
Investment portfolio details for SeraCare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Plasma igniter systems are manufactured and distributed globally.
|
Locked | Locked | 2017 | Locked | |
|
Manufactures, and markets high quality immunochemicals for life science and in vitro diagnostics
|
Locked | Locked | 1979 | Locked |
Complete acquisition details for SeraCare
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SeraCare
Detailed financials for SeraCare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Seracare Comparisons
Peer comparison for SeraCare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SeraCare
SeraCare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Proteins, antibodies, and molecular tools are manufactured for research applications.
|
|
| Locked | Locked | Locked |
Research services, reagents, and kits for biotech applications are provided.
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
|
| Locked | Locked | Locked |
Molecular biology reagents and kits are supplied for research applications.
|
Detailed competitors of SeraCare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seracare
Complete news archive for SeraCare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SeraCare
SeraCare was founded in 1984 and raised its 1st funding round 28 years after it was founded.
SeraCare is headquartered in Milford, United States.
Charlie Mamrak is the current CEO of SeraCare.
SeraCare Life Sciences was founded in 1984 and is based in Milford, United States. Operations focus on the life sciences sector, where diagnostic controls, plasma-derived reagents, molecular biomarkers, biobanking, and contract research services are offered to support diagnostics and therapeutics development. Clients include researchers, in vitro diagnostics manufacturers, and clinical labs worldwide. The company was acquired by Linden in 2012 and operates as a private portfolio entity.
SeraCare's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
SeraCare offers NGS Solutions, Controls & Reference Materials, and Custom Services.
SeraCare has made 2 acquisitions, including American Plasma Energy, and KPL.
SeraCare has 4 investors. Key investors include LGC, MidCap Financial, Five Points Capital, and Linden Capital Partners.